x

Transcode Therapeutics, Inc. (Nasdaq:RNAZ)

Health Care/Life Sciences • Pharmaceuticals
CIK 1829635
Company

TransCode Therapeutics, Inc. engages in the development and commercializing of diagnostics and therapeutics for the detection and treatment of cancer. The company was founded by Robert Michael Dudley, Zdravka Medarova, and Anna Moore in January 2016 and is headquartered in Boston, MA.

Address
6 Liberty Square
Suite 2382
Boston, Massachusetts 02109
Employees
19
Stock Info
Close
$0.7300
Day Range
0.7005 - 0.7300
52 Week Range
0.5600 - 392.0000
Average volume
569.63K
Short Interest
220.91K (02/15/24)
% of Float Shorted
3.38%
Market Cap
$4.6M
Revenue
N/A
Net Income
-$17.56M
2020 Sales Growth
N/A
Rev. per Employee
N/A
P/E Ratio
N/A
EPS
-$782.8560
Yield
N/A
Dividend
N/A
Ex-Dividend Date
N/A
Key Executives
Board Of Directors
Executive Chairman
Philippe P Calais PhD
Independent Director
Erik Manting PhD
Independent Director
Magda Marquet PhD
SEC filings
DateFormEvent
20 Dec, 2024 8-K
19 Dec, 2024 PRE 14A
17 Dec, 2024 EFFECT
12 Dec, 2024 D
6 Dec, 2024 S-1
2 Dec, 2024 8-K
29 Nov, 2024 8-K
25 Nov, 2024 8-K
14 Nov, 2024 10-Q
13 Nov, 2024 DEFA14A
6 Nov, 2024 SC 13G/A
6 Nov, 2024 8-K
6 Nov, 2024 DEFA14A
28 Oct, 2024 DEF 14A
15 Oct, 2024 PRE 14A
27 Sep, 2024 8-K
28 Aug, 2024 8-K
16 Aug, 2024 8-K
14 Aug, 2024 10-Q
26 Jul, 2024 SC 13G
24 Jul, 2024 424B5
24 Jul, 2024 8-K
22 Jul, 2024 424B5
21 Jun, 2024 SC 13D
18 Jun, 2024 4
18 Jun, 2024 4
18 Jun, 2024 4
18 Jun, 2024 4
14 Jun, 2024 8-K/A
13 Jun, 2024 8-K
10 Jun, 2024 DEFA14A
7 Jun, 2024 8-K
7 Jun, 2024 DEFA14A
20 May, 2024 DEFR14A
15 May, 2024 10-Q
15 May, 2024 8-K
13 May, 2024 DEFA14A
10 May, 2024 8-K
10 May, 2024 PRE 14A
29 Apr, 2024 DEF 14A
29 Apr, 2024 ARS
23 Apr, 2024 8-K
5 Apr, 2024 8-K
1 Apr, 2024 10-K
15 Feb, 2024 SC 13G/A
14 Feb, 2024 SC 13G/A
13 Feb, 2024 SC 13G/A
31 Jan, 2024 8-K
22 Jan, 2024 424B4
22 Jan, 2024 8-K
18 Jan, 2024 S-1/A
17 Jan, 2024 CORRESP
17 Jan, 2024 S-1/A
17 Jan, 2024 CORRESP
16 Jan, 2024 UPLOAD
16 Jan, 2024 8-K CEO Change
11 Jan, 2024 S-1
8 Jan, 2024 8-K
4 Jan, 2024 DEFA14A
18 Dec, 2023 DEF 14A
8 Dec, 2023 8-K
8 Dec, 2023 PRE 14A
7 Dec, 2023 SC 13G
4 Dec, 2023 8-K
1 Dec, 2023 424B5
14 Nov, 2023 8-K
14 Nov, 2023 10-Q
9 Nov, 2023 8-K
27 Oct, 2023 8-K
26 Oct, 2023 424B5
24 Oct, 2023 8-K
10 Oct, 2023 SC 13D/A
2 Oct, 2023 4
2 Oct, 2023 4
28 Sep, 2023 8-K
27 Sep, 2023 424B4
26 Sep, 2023 SC 13G
25 Sep, 2023 EFFECT
25 Sep, 2023 CORRESP
25 Sep, 2023 CORRESP
25 Sep, 2023 S-1/A
25 Sep, 2023 CORRESP
25 Sep, 2023 CORRESP
22 Sep, 2023 CORRESP
22 Sep, 2023 CORRESP
22 Sep, 2023 CORRESP
15 Sep, 2023 CORRESP
15 Sep, 2023 CORRESP
11 Sep, 2023 S-1/A
31 Aug, 2023 UPLOAD
29 Aug, 2023 S-1
24 Aug, 2023 8-K
14 Aug, 2023 10-Q
4 Aug, 2023 8-K
28 Jul, 2023 8-K
22 Jun, 2023 4
16 Jun, 2023 SC 13D/A
14 Jun, 2023 4/A
13 Jun, 2023 4
8 Jun, 2023 8-K
7 Jun, 2023 424B4
6 Jun, 2023 CORRESP
6 Jun, 2023 EFFECT
6 Jun, 2023 S-1/A
5 Jun, 2023 S-1/A
5 Jun, 2023 CORRESP
25 May, 2023 UPLOAD
22 May, 2023 8-K
19 May, 2023 4
19 May, 2023 4
19 May, 2023 4
19 May, 2023 4
19 May, 2023 4
19 May, 2023 S-1
19 May, 2023 8-K
18 May, 2023 8-K
15 May, 2023 10-Q
10 May, 2023 8-K
10 May, 2023 4
10 May, 2023 4
10 May, 2023 4
14 Apr, 2023 424B5
14 Apr, 2023 8-K
10 Apr, 2023 ARS
10 Apr, 2023 DEF 14A
31 Mar, 2023 PRE 14A
31 Mar, 2023 10-K
31 Mar, 2023 8-K
31 Mar, 2023 8-K
17 Feb, 2023 8-K
17 Feb, 2023 424B5
14 Feb, 2023 RW
10 Feb, 2023 SC 13G/A
1 Feb, 2023 S-1
1 Feb, 2023 8-K
20 Dec, 2022 SC 13G
20 Dec, 2022 SC 13G
20 Dec, 2022 SC 13D
16 Dec, 2022 EFFECT
14 Dec, 2022 4
14 Dec, 2022 CORRESP
14 Dec, 2022 4
14 Dec, 2022 4
14 Dec, 2022 4
14 Dec, 2022 UPLOAD
13 Dec, 2022 S-3
9 Dec, 2022 8-K
6 Dec, 2022 RW
30 Nov, 2022 8-K
30 Nov, 2022 S-1/A
28 Nov, 2022 S-1
14 Nov, 2022 10-Q
14 Nov, 2022 8-K
27 Oct, 2022 SC 13G/A
16 Sep, 2022 4
15 Aug, 2022 10-Q
15 Aug, 2022 8-K
3 Aug, 2022 8-K
29 Jul, 2022 DRS
23 Jun, 2022 8-K
22 Jun, 2022 4
22 Jun, 2022 4
22 Jun, 2022 4
17 Jun, 2022 4
9 Jun, 2022 S-8
1 Jun, 2022 4
16 May, 2022 8-K
16 May, 2022 10-Q
2 May, 2022 DEFA14A
2 May, 2022 DEF 14A
1 Apr, 2022 8-K
31 Mar, 2022 10-K
2 Mar, 2022 4
11 Feb, 2022 SC 13G/A
3 Feb, 2022 4
3 Feb, 2022 4
15 Nov, 2021 8-K
15 Nov, 2021 10-Q
30 Sep, 2021 8-K
23 Aug, 2021 10-Q
23 Aug, 2021 8-K
21 Jul, 2021 SC 13G
13 Jul, 2021 S-8
13 Jul, 2021 8-K
9 Jul, 2021 424B4 IPO completed
8 Jul, 2021 3
8 Jul, 2021 SEC STAFF
8 Jul, 2021 EFFECT
8 Jul, 2021 3
8 Jul, 2021 3
8 Jul, 2021 3
8 Jul, 2021 3
8 Jul, 2021 3
8 Jul, 2021 3
6 Jul, 2021 CORRESP
6 Jul, 2021 CORRESP
2 Jun, 2021 S-1/A
1 Jun, 2021 CORRESP
14 May, 2021 CORRESP
6 May, 2021 CORRESP
6 May, 2021 CORRESP
3 May, 2021 S-1/A
27 Apr, 2021 CERT
26 Apr, 2021 8-A12B
23 Apr, 2021 CORRESP
23 Apr, 2021 CORRESP
16 Apr, 2021 CORRESP
16 Apr, 2021 S-1/A
14 Apr, 2021 UPLOAD
8 Apr, 2021 S-1/A
24 Mar, 2021 S-1/A
11 Mar, 2021 CORRESP
26 Feb, 2021 S-1
28 Jan, 2021 SEC STAFF
27 Jan, 2021 DRS/A
27 Jan, 2021 DRSLTR
15 Jan, 2021 UPLOAD
18 Dec, 2020 DRS
Last update:2024-03-08 12:05:14.951570
Transcode Therapeutics, Inc. by TradingView

Sign Up to Subscribe